SYNAPTICS Inc financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data SYNAPTICS Inc files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	1,718	1,630	1,472	1,334	1,340	1,740	1,355	959	1,074	1,197
Cost of revenue	1,195	1,150	975	791	728	797	639	520	594	662
Gross profit	524	480	497	543	611	943	716	440	480	535
Research and development	292	363	343	303	313	367	351	336	347	382
Selling, general and administrative	138	154	131	127	145	168	175	161	180	198
Operating expenses	459	542	503	474	464	593	562	541	575	603
Operating income	64.7	-61.9	-6.3	68.9	147	350	154	-102	-94.1	-67.1
Interest expense	6	22.2	21.2	22.5	29.5	30.2	55.5	65.3	39.8	23.4
Interest income		2.3	3.9	7.9	2.9	3	27.2	42.3	26.9	11.1
Other non-operating income	0.7	2.3	3.9	-3.7	0	-5.5	-27.4	-25	-24.7	-18.6
Pre-tax income	61.3	-81.8	-20.8	159	120	321	126	-125	-114	-79.4
Income tax	12.2	40.5	0.3	38.6	31.4	64.6	52.4	-250	-65.7	411
Net income	48.8	-124	-22.9	119	79.6	258	73.6	126	-47.8	-491
EBITDA	97.9	-23	29.3	95.6	169	374	182	-74	-65.2	-36.3
EPS, basic	1.40	-3.63	-0.66	3.54	2.29	6.60	1.86	3.20	-1.22	-12.62
EPS, diluted	1.37	-3.63	-0.66	3.41	2.08	6.33	1.83	3.16	-1.22	-12.62
Shares, basic (weighted)	34.8	34.2	34.6	33.6	34.8	0	39.6	39.2	39.3	38.9
Shares, diluted (weighted)	35.6	34.2	34.6	34.8	38.3	0	40.2	39.7	39.3	38.9

Balance sheet

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Cash and equivalents	368	301	328	763	836	824	925	877	392	443
Short-term investments					0	52	9.6	0	61	0
Receivables	255	289	230	195	228	322	164	142	130	164
Inventory	131	131	159	102	82	170	137	114	140	156
Other current assets	37.6	18.2	14.6	16.9	33.1	35.6	36.6	29	29.6	24.1
Total current assets	792	740	731	1,078	1,180	1,403	1,272	1,162	752	787
Property, plant and equipment	114	118	103	84.3	91.2	62.9	66.4	75.5	72.1	86.9
Lease right-of-use assets			27.8	21	31.7	61.2	49	46.8	45.2	37.1
Goodwill	207	373	373	361	570	807	816	816	872	872
Intangible assets	101	219	145	93.4	302	390	299	288	262	188
Other non-current assets	53.1	50.5	58.1	77.7	52.7	134	41.1	137	217	162
Total assets	1,267	1,500	1,410	1,694	2,227	2,858	2,611	2,825	2,584	2,102
Accounts payable	136	157	98.3	60.6	97.6	142	45.8	87.5	98.5	82.6
Accrued liabilities	31.9	25.4	30.4	59.5	76.4	145	108	184	172	179
Short-term debt	15					6	6	6	0	440
Total current liabilities	310	284	254	244	787	463	260	277	271	701
Long-term debt	202			100	394	976	972	967	835	398
Lease liabilities				14.6	24	51.5	42.4	37.9	35.8	30.3
Other non-current liabilities	14.1	36	30.3	44	78.5	153	93.5	114	83.8	73.5
Total liabilities	527	771	753	875	1,260	1,592	1,368	1,358	1,190	1,173
Total debt	217			100	394	997	991	973	835	837
Paid-in capital	1,005	1,195	1,266	1,340	1,392	924	1,009	1,107	1,212	1,330
Retained earnings	714	606	584	701	781	1,039	1,112	1,238	1,190	699
Treasury stock	-980	-1,074	-1,192	-1,223	-1,205	-695	-878	-878	-1,007	-1,100
Other comprehensive income	1.5	1.5			0	-1.8	0
Shareholders' equity	740	729	656	819	967	1,266	1,243	1,467	1,395	930
Total equity	740	729	656	819	967	1,266	1,243	1,467	1,395	930
Total liabilities and equity	1,267	1,500	1,410	1,694	2,227	2,858	2,611	2,825	2,584	2,102
Shares outstanding	34.6	35.2	33.3	34.1	35.3	39.6	38.6	39.6	38.6	39.1

Cash flow statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Net income	48.8	-124	-22.9	119	79.6	258	73.6	126	-47.8	-491
Depreciation and amortization	33.2	38.9	35.6	26.7	21.6	24	27.4	27.6	28.9	30.8
Stock-based compensation	61.8	71.3	59	49.3	66.1	101	122	119	113	149
Deferred income tax	-22.9	4.9	-15.2	2.4	-8.9	-29.7	-25.9	-289	-75.4	404
Change in receivables	-2.6	-22.7	64.3	31	-25.9	-81.1	161	22.4	12.3	-33.7
Change in inventory	15	79.5	-27.5	43	43.4	-54.2	24.6	6.5	-25.1	-17.1
Change in payables	-38.4	6.2	-55.8	-36.2	32.2	23.2	-95.6	38.9	10.8	-13.7
Cash from operations	153	145	154	222	319	463	332	136	142	149
Capital expenditures	-31.4	-34.1	-23.7	-16.3	-21.1	-31.1	-34.2	-33.8	-25.8	-48
Acquisitions		-397		0	-627	-501	-15.5	0	-201	0
Purchases of investments						-5.8	0	-16.6	-61	0
Sales and maturities of investments	7.5		2.8	0	95.8	24.4	22.2	0
Cash from investing	-42.3	-439	-20.9	120	-523	-483	-6	-158	-298	13
Debt issued				0	400	600	0	0	440	0
Debt repaid	-18.8	-220
Stock issued	10.7	16.7	5.2	23.9	23.9	5.3	3.3	0.3
Share buybacks	-88	-93.6	-119	-30.2	0	0	-184	0	-128	-92.7
Cash from financing	-94.1	227	-107	93.9	274	14.3	-221	-25.1	-331	-112
Exchange rate effect	-0.9		0.1	0	2.2	-6.6	-3.5	-0.9	1.9	0.1
Net change in cash	15.6	-66.8	26.8	436	72.9	-12.3	101
Free cash flow	122	111	131	206	298	432	297	102	116	101
Interest paid	6	3.8	3.6	3.7	9.6	25	51.9	63.4	38.7	20.5
Income taxes paid	22.1	26.4	16.4	18.9	39.7	42	91.4	55.2	47.2	3.2

Key metrics

Worked out from the statements above. Latest values use fiscal 2026. Valuation uses the share price of $102.72 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	44.7%	Gross profit / revenue.
Operating margin	-5.6%	Operating income / revenue.
EBITDA margin	-3.0%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	-6.6%	Pre-tax income / revenue.
Net margin	-41.0%	Net income / revenue.
FCF margin	8.5%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	12.5%	Cash from operations / revenue.
Return on equity (ROE)	-42.2%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	-20.9%	Net income / average total assets.
Return on invested capital (ROIC)	-3.4%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	31.9%	Research and development expense / revenue.
SG&A / revenue	16.6%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	12.5%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	4.0%	Capital expenditures / revenue.
D&A / revenue	2.6%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	11.4%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-4.0%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	-2.2%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	11.4%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-9.2%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	-2.6%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	5.2%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	-23.3%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	-14.1%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-12.7%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	-30.1%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	-19.4%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-33.4%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-9.2%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	-0.8%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-18.7%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-7.0%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-1.1%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-1.0%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-1.1%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	0.3%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.12x	Current assets / current liabilities.
Quick ratio	0.86x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.63x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.90x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	39.8%	Total debt / total assets.
Liabilities / assets	55.8%	Total liabilities / total assets.
Net debt	$394.8M	Total debt - cash - short-term investments. Negative means more cash than debt.
Interest coverage	-2.87x	Operating income / interest expense.
Working capital	$85.7M	Current assets - current liabilities.
Goodwill and intangibles / assets	50.4%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$130.6M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.51x	Revenue / average total assets.
Fixed asset turnover	15.1x	Revenue / average property, plant and equipment.
Inventory turnover	4.47x	Cost of revenue / average inventory.
Days inventory	82 days	365 x average inventory / cost of revenue.
Receivables turnover	8.14x	Revenue / average receivables.
Days sales outstanding	45 days	365 x average receivables / revenue.
Days payables	50 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	77 days	Days inventory + days sales outstanding - days payables.
Capex / operating cash flow	32.1%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$12.62	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic	-$12.62	Net income per basic share, as reported (split-adjusted).
Revenue per share	$30.78	Revenue / diluted weighted shares.
FCF per share	$2.61	Free cash flow / diluted weighted shares.
Operating cash flow per share	$3.84	Cash from operations / diluted weighted shares.
Book value per share	$23.80	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$3.34	Tangible book value / shares outstanding.
Cash per share	$11.33	(Cash + short-term investments) / shares outstanding.
Buybacks / FCF	91.4%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$4.02B	Share price x shares outstanding.
Enterprise value	$4.41B	Market cap + total debt - cash - short-term investments.
P/S	3.36x	Market cap / revenue.
P/B	4.32x	Market cap / shareholders' equity. Only when equity is positive.
P/FCF	39.6x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	26.9x	Market cap / cash from operations, when positive.
EV/Sales	3.69x	Enterprise value / revenue.
EV/FCF	43.5x	Enterprise value / free cash flow, when both are positive.
FCF yield	2.5%	Free cash flow / market cap.
Earnings yield	-12.2%	Net income / market cap (the inverse of P/E).
Shareholder yield	2.3%	(Dividends paid + share buybacks) / market cap.

What was SYNAPTICS Inc's revenue in fiscal 2026?

SYNAPTICS Inc reported revenue of $1.20B for fiscal 2026, 11.4% higher than the year before.

Was SYNAPTICS Inc profitable in fiscal 2026?

No. It reported a net loss of $490.8M.

How much free cash flow did SYNAPTICS Inc generate in fiscal 2026?

Cash from operations of $149.4M minus capital expenditures of $48.0M left free cash flow of $101.4M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to SYNAPTICS Inc